Skip to content

AdaptHealth AHCO Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin18.3%-0.5pp18.8%-0.6pp19.3%-0.1pp19.4%-0.4pp19.8%-1.0pp
Net margin-2.4%-0.2pp-2.2%-4.7pp2.5%0.0pp2.5%-0.1pp2.6%-0.1pp
EBITDA margin12.7%-0.3pp13.1%-6.5pp19.6%+0.1pp19.5%+0.9pp18.6%-0.7pp
Free cash flow margin5.8%-0.9pp6.8%+0.2pp6.5%-0.6pp7.1%-1.3pp8.5%+1.2pp
Returns
Return on equity-5.2%-0.6pp-4.6%-9.8pp5.2%0.0pp5.2%-0.4pp5.6%-0.3pp
Return on assets-1.8%-0.2pp-1.6%-3.5pp1.9%0.0pp1.8%-0.1pp1.9%-0.1pp
Return on invested capital0.7%-0.5pp1.2%-3.0pp4.2%0.0pp4.2%-0.4pp4.6%-0.4pp
Efficiency
Asset turnover0.7×0.0×0.7×0.0×0.7×0.0×0.7×0.0×0.7×0.0×
Inventory turnover18.6×+0.5×18.1×-0.5×18.6×-0.6×19.1×-2.7×21.9×+1.5×
Liquidity
Current ratio0.9×-0.1×-0.1×1.1×0.0×1.1×-0.2×1.3×0.0×
Quick ratio0.7×-0.1×0.8×0.0×0.9×0.0×0.8×-0.2×1.1×0.0×
Cash ratio0.1×-0.1×0.1×0.0×0.1×0.0×0.1×0.0×0.1×-0.1×
Leverage
Debt-to-equity1.3×+0.1×1.3×+0.1×1.2×-0.1×1.2×-0.1×1.3×0.0×
Debt-to-assets0.5×0.0×0.4×0.0×0.4×0.0×0.4×0.0×0.5×0.0×
Net debt / EBITDA4.7×+0.4×4.2×+1.4×2.9×-0.1×
Per Share
Book value per share$11.10-1.2%$11.24-4.6%$11.78+1.7%$11.58-0.4%$11.63+0.3%
Valuation
Market capitalization$1.36B+20.4%$1.35B+11.4%$1.21B+2.4%$1.18B-19.1%$1.46B+14.1%
Enterprise value$3.32B+4.2%$3.15B+3.7%$3.03B-1.0%$3.06B-12.8%$3.51B+6.4%
Price / sales0.4×+0.1×0.4×0.0×0.4×0.0×0.4×-0.1×0.5×+0.1×
Price / book0.9×+0.2×0.9×+0.1×0.7×0.0×0.7×-0.2×0.9×+0.1×
EV / EBITDA7.9×+2.7×7.4×+2.7×4.8×-0.1×4.9×
EV / sales0.0×0.0×0.9×0.0×0.9×-0.1×1.1×+0.1×
Free cash flow yield14.1%-10.2pp16.3%-1.3pp17.6%-2.0pp19.6%+0.8pp18.8%+0.4pp
Earnings yield-5.8%-13.4pp-5.2%-12.0pp6.8%0.0pp6.8%+1.0pp5.8%-1.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are AdaptHealth's profit margins?
AdaptHealth (AHCO) runs a 18.3% gross margin and a 8.0% operating margin, with a -2.4% net margin.
Where do AdaptHealth's ratios come from?
Every ratio is computed from AdaptHealth's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.